Advertise on podcast: Passionate Pioneers with Mike Biselli

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview: Geography should never determine whether a patient lives or dies. Our next guest, Dr. Sarah Matt, is on a mission to make that vision a reality. A surgeon turned health technology strategist, Sarah has spent over two decades breaking down the barriers that separate patients from care. From leading Oracle's $28 billion Cerner integration to architecting the first U.S. remote robotic surgery network, she's been at the forefront of healthcare's digital transformation. Now, as a national bestselling author of The Borderless Healthcare Revolution, Sarah is equipping healthcare leaders with a practical framework to eliminate physical, financial, cultural, digital, and trust barriers to care. Join us to discover how we can build a truly borderless healthcare system. Let's go! Episode Highlights: Five Pillars of Access: Physical, financial, cultural, digital, and trust barriers—with cultural and trust most overlookedFrom Bedside to Billions: Sarah left the OR to impact millions through technology instead of 20 patients a day2026 is the Year of Catch Up: Fix data governance and interoperability before AI can deliver real resultsActionable Over Theoretical: Every chapter includes a builder's box and checklist for immediate actionNew Leadership Required: Leaders must think faster, embrace uncertainty, and operate in the gray zone About our Guest: Sarah Matt, MD, MBA, is a surgeon turned health technology strategist, author, and speaker. Her work focuses on how digital tools, from remote surgery to telemedicine to AI, can expand access to healthcare and eliminate the traditional boundaries that separate patients from care. With over two decades of experience at the intersection of medicine and innovation, Dr. Matt has held leadership roles at Oracle Health, NextGen, and multiple health tech startups. She has designed and deployed systems that reach patients around the world, including hard-to-serve and underserved populations. A practicing physician, Dr. Matt continues to treat patients in rural and charity-based settings, keeping her closely connected to the human side of healthcare access. She speaks widely at healthcare and technology conferences and has appeared on national panels about artificial intelligence, care delivery reform, and digital transformation. She is also the author of The Borderless Healthcare Revolution: The Definitive Guide to Breaking Geographic Barriers Through Technology. A graduate of Cornell University, SUNY Upstate Medical University and UT Austin’s McCombs School of Business, she blends clinical acumen with deep technical knowledge to challenge the status quo and to reimagine what healthcare can look like when geography no longer dictates your care. Links Supporting This Episode: Dr. Sarah Matt Website: CLICK HEREspan class="ql-ui"...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview: Healthcare still doesn't truly know "who is who" — and that identity crisis is costing health systems patients, trust, and growth. Our next guest, Clay Ritchey, is tackling this challenge head-on as CEO of Verato. With more than two decades of experience driving growth and innovation across market-leading healthcare technology organizations, Clay brings a unique perspective on why identity intelligence is the hidden driver of patient loyalty and better outcomes. Scaling his previous company through hyper-growth and a successful merger, he understands what it takes to seamlessly implement solutions that transform how healthcare organizations engage with consumers. Join us to discover how Verato is powering a single source of truth for identity across healthcare and why being "impatient as hell" is exactly what this industry needs. Let's go! Episode Highlights: Be impatient as hell — Clay's advice to healthcare innovators is to maintain urgency and not let the slow pace of the industry get in your way.Healthcare's identity crisis is blocking digital transformation — The High Tech Act moved healthcare off paper records, but we missed solving identity, leaving fragmented data that prevents a true 360-degree patient view.7 in 10 healthcare leaders are losing patients due to poor experiences — Verato's national study revealed that fragmented identity data is directly driving patient attrition and eroding loyalty.Consumerism is reshaping healthcare — Less than 25% of millennials have a primary care physician, and patients are increasingly willing to drive past hospitals for better experiences elsewhere.Identity intelligence is foundational for AI success — Organizations are investing in identity data quality now because high-fidelity data is essential to trustworthy AI outcomes. About our Guest: Clay brings more than 20 years of experience driving growth and innovation in market-leading healthcare technology organizations to Verato. As CEO, Clay is passionate about working with healthcare, life science, and government organizations across the care continuum to transform the way that consumers and patients engage with them to build deeper relationships resulting in improved outcomes and sustainable growth for our customers. Prior to joining Verato, Clay served as CEO of Evariant, a healthcare SaaS CRM and big data analytics company, achieving hyper-growth of the organization and leading them to a successful merger. Prior roles also include Chief Marketing Officer at Imprivata, CEO at Maryland-based Equinox Healthcare, and Vice President of Marketing and Strategy at Hill-Rom IT Solutions. Clay received his MBA from Harvard Business School and his BSEE, with Highest Distinction, from The Pennsylvania State University. Links Supporting This Episode: Clay Ritchey LinkedIn page: CLICK HEREli

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview: Healthcare's workforce crisis demands innovative solutions that transform how we develop and deploy talent. Our next guest, Van Ton-Quinlivan, is addressing this challenge as CEO of Futuro Health, building the nation's largest network of allied healthcare workers. With extensive experience spanning private, public, and nonprofit sectors, Van brings a unique perspective to workforce development shaped by her personal journey as a Vietnamese refugee who found opportunity through education. Now she's dedicated to unlocking that same potential for others. Recognized as one of the Top 50 Women Leaders in Healthcare and among the 100 Most Influential Higher Education Leaders, Van shares Futuro Health's pioneering approach to creating community-based education pipelines that serve both workers seeking meaningful careers and employers needing compassionate, skilled talent. Join us to discover how inclusive workforce development is transforming lives and strengthening healthcare communities nationwide. Let's go! Episode Highlights: Education as a gateway to opportunity - Van shares her personal journey as a Vietnamese refugee and how education transformed her life, fueling her passion to unlock opportunities for others through workforce developmentBuilding the largest allied health network - Futuro Health is creating community-based education and training pipelines to address the critical shortage of healthcare workers across the nationHuman Touch Healthcare program - A six-week signature program focused on emotional intelligence, cultural competence, and teamwork designed specifically for adult learners without traditional lecture formatsBalancing AI and human connection - As healthcare adopts AI, strengthening uniquely human skills like compassion becomes essential to distinguish when to use human agents versus AI agentsJPMorgan Chase Foundation partnership - Upcoming grant will enable 12 employers (providers, health plans, or rural networks) to implement the Futuro Health method for growing local healthcare workers from untapped communities About our Guest: Van Ton-Quinlivan is a nationally recognized workforce development leader with a career spanning the private, public, and nonprofit sectors. As CEO of Futuro Health, she’s building the nation’s largest network of allied healthcare workers. In 2022, she was appointed by Governor Newsom to help shape California’s healthcare workforce education and training. Van is the author and podcast host of WorkforceRx, promoting agile, multicultural solutions for employers, educators, and workers. Featured in major media and a sought-after keynote speaker, she’s been named one of the Top 50 Women Leaders in Healthcare (2024) and among the 100 Most Influential Higher Education Leaders (2025). She serves on several national boards and holds an MBA and MA in Education Policy from Stanford University. Born in Vietnam and raised in Hawaii, Van now lives in California. A new empty nester, she enjoys morning coffee walks with her husband, and recently took up taiko...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Artificial intelligence is transforming every industry, but without proper governance, boards risk investing in tech hype rather than strategic value.  Our next guest, JaeLynn Williams, is helping pioneer the opportunities in front of us as CEO of Decision Frame. With a remarkable career leading innovation across healthcare and aviation—from launching 3M's award-winning 360 Encompass AI platform to guiding Air Methods Corporation through a complex $1.3 billion turnaround—JaeLynn brings unparalleled insight to AI adoption.  Driven by the belief that intellectual curiosity and discomfort fuel breakthrough leadership, she's developed the Board AI Governance Index™, a groundbreaking framework helping boards, entrepreneurs, and executives balance innovation with accountability.  Join us to discover how Decision Frame's proprietary tools are enabling leaders to harness AI's transformative potential responsibly while protecting shareholder value in an era of unprecedented disruption. Let's go! Episode Highlights: Intellectual curiosity drives innovation - Success comes from diving in, staying uncomfortable, and moving into uncharted territory with a learner's mindsetAI is a leadership challenge, not just a technology issue - Unlike traditional IT governance, AI transforms how work gets done across entire organizations and requires comprehensive oversight95% of AI pilots fail to deliver value - Without proper governance frameworks, organizations risk wasting capital on countless pilots that don't translate to ROI or meaningful outcomesData governance is the foundation - Clean, well-governed data is essential for AI success; without it, organizations face compliance issues and failed implementationsThe Board AI Governance Index™ creates a common measurement language - The framework enables leaders to articulate their AI maturity level and strategic choices to investors without revealing proprietary information About our Guest:  JaeLynn Williams is a nationally recognized executive leading innovation in healthcare, aviation, and artificial intelligence. She most recently served as Chief Executive Officer of Air Methods Corporation, a $1.3 billion national provider of air medical and aviation services, where she effectively guided the company through a complex turnaround and strategic transformation. Previously, she held senior leadership roles at GE Healthcare Digital, where she gained global experience helping health systems worldwide modernize enterprise imaging, clinical, and revenue cycle systems. Earlier in her career, she was President of 3M Health Information Systems (HIS), where she led the innovation and launch of the award-winning 360 Encompass platform — one of healthcare’s largest and most successful AI-driven solutions, incorporating machine learning and natural language processing to transform clinical documentation and coding, and now relied on by hospitals across the United States. Today, JaeLynn leads Decision Frame, which develops tools to help boards, entrepreneurs, and executives adopt artificial intelligence responsibly while harnessing its transformative potential. Its suite of proprietary frameworks — the Board AI Governance Index™, Small Business AI Index™, and Middle Market AI Index™ — enables leaders to evaluate readiness, manage risk, and explore new opportunities. With a career marked by pioneering in overlooked yet vital areas, JaeLynn is a highly sought-after advisor, speaker, and board member

The best biotech and pharmaceutical innovations mean nothing if they can't be protected—and protected fast.  Our next guest, Josh Goldberg, is solving this challenge as co-managing partner at Nath, Goldberg & Meyer, the #1 ranked patent law firm for biotech and pharmaceutical technologies.  With nearly three decades of IP law experience and a unique background as a lab researcher, Josh brings an insider's understanding of how innovation actually happens.  He's helped industry leaders like Amgen, Takeda, and GlaxoSmithKline turn breakthrough treatments into patent-protected portfolios—often in under a year instead of the typical four-year timeline.  Driven by a passion for focus and strategic IP timing, Josh shares his pioneering approach to biotech and pharmaceutical patent prosecution.  Join us to discover how smart IP strategy drives licensing power, regulatory success, and company valuation. Let's go! Episode Highlights: Focus drives success – Companies fail by trying to do everything at once; staying deliberate and focused is key to making real impactOne-year patent timelines vs. four years – Josh uses USPTO's Track 1 program to secure patents in record time, improving fundraising and M&A positioningClient-centered approach wins – Listening to unique client needs instead of one-size-fits-all strategies earned the firm its #1 rankingDiagnostic patents are back – New USPTO Director signals the patent office is "open for business" again after a decade of restrictionsScientist turned patent attorney – Josh's lab background gives him insider understanding of how innovation actually happens About our Guest:  Joshua is the patent attorney innovation-driven pharmaceutical companies call when they need to turn complicated technologies into protected assets in record time. As co-managing partner at Nath, Goldberg & Meyer—the #1 ranked patent law firm for biotech and pharmaceutical technologies in both 2024 and 2025—Joshua leads IP efforts across industries like biotech, pharma, agriculture, renewable energy, and advanced materials.  Whether it’s a blockbuster acne treatment like DUAC, a vitamin D analog lotion like Sorilux, OTC solutions like Salonpas and Germagic, or a leading drug used to reduce stomach acid and treat conditions like GERD, ulcers, and heartburn—like Protonix—Joshua helps turn high-stakes R&D into patent-protected portfolios, often in under a year instead of the typical four-year timeline. Though his climate and agricultre IP expertise has made him famous as the “green patent guy,” Joshua moves between disciplines skillfully and has helped industry leaders like Amgen, Takeda, Guilford Pharmaceuticals, Mayne, and Stiefel Laboratories (which was acquired by GlaxoSmithKline) build pharma portfolios that hold up under investor, acquirer, and FDA scrutiny. His journey didn’t begin in IP law, but in the lab, researching experimental pharmaceutical delivery systems. It gave him an edge most attorneys don’t have: understanding how innovation actually happens, and how to protect it without slowing a business down.  Links Supporting This Episode:  Nath, Goldberg & Meyer Website: CLICK HEREJoshua Goldberg LinkedIn page: CLICK HERENath, Goldberg & Meyer LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page:...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Growing a company from $46,000 to $30 million in six years doesn't happen by accident—it requires vision, grit, and the right team.  Our next guest, Beth Lachance, is the CEO and founder of Global Medical Virtual Assistants, where she's revolutionizing administrative support for medical practices nationwide.  With 16 years as an entrepreneur and over 22 years of healthcare leadership experience, she brings strategic vision and hands-on execution to building high-performing distributed teams.  Driven by a passion for operational excellence and leveraging global talent, Beth shares how GMVA is transforming healthcare staffing through HIPAA-compliant virtual assistants from the Philippines.  Join us to discover how her team is helping practices reclaim time, reduce costs, and refocus on patient care. Let's go! Episode Highlights: The Right Team Matters - Finding the right advisors and team members is critical, even when it means parting ways with early supporters.Leadership Evolves with Growth - Different business stages require different leaders; Beth is now bringing on a CFO as GMVA scales.$46K to $30M in Six Years - GMVA's explosive revenue growth demonstrates massive demand for virtual healthcare staffing.Reimagining Healthcare Work - GMVA transforms medical practices through remote administrative support, freeing providers to focus on patients.Tough Decisions Drive Success - Beth learned that moving on from trusted early team members, though painful, unlocks company potential. About our Guest:  Beth Lachance is the CEO and founder of Global Medical Virtual Assistants (GMVA), where she drives sustainable growth and operational excellence for a company revolutionizing administrative support for U.S. medical practices. With 16 years as an entrepreneur specializing in real estate and over 22 years of corporate leadership in Surgical Device, Pharmaceutical, and Specialty Pharmacy industries, Beth blends strategic vision with hands- on execution to build high-performing teams and achieve long-term success. A former Division I gymnast on full scholarship at the University of Florida, Beth earned her Bachelor of Science in Health Sciences, a testament to her discipline and goal-driven leadership. Links Supporting This Episode:  Global Medical Virtual Assistants Website: CLICK HEREBeth Lachance LinkedIn page: CLICK HEREGlobal Medical Virtual Assistants LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: a...

Earwax affects over 35 million Americans and is the leading cause of conductive hearing loss- yet the procedure to remove it hasn't changed in 200 years.  Our next guest, Sahil Diwan, is revolutionizing ear care as CEO of SafKan Health and creator of OtoSet®- the world's first FDA-cleared automated ear cleaning device.  What began as a college dorm room experiment to solve his brother's chronic earwax problem has evolved into a viral phenomenon with over 250 million social media views and a network of clinics nationwide.  Driven by a vision to become the "front door to ear and hearing care," Sahil shares how SafKan is using consumer-style virality to drive clinical adoption and create unprecedented access to care.  Join us to discover how this first-generation immigrant is bridging medtech innovation with patient demand. Let's go! Episode Highlights: From Dorm Room to FDA Clearance: Started with 3D-printed prototypes in a college dorm to solve his brother's chronic earwax problem.Viral Social Media Strategy: Generated over 1 billion views in 18 months, using consumer virality to drive patient demand for a medical device.Rapid Clinic Expansion: Opening a new location every 2-3 weeks, aiming for 50 clinics by end of next year.Front Door to Ear Care: Creating accessible ear cleaning plus hearing screenings to identify hearing loss years earlier than traditional methods.Power of Mentorship: Finding experienced mentors, especially for FDA processes, saved significant time, stress, and money. About our Guest:  Sahil Diwan is the Co-Founder and CEO of SafKan Health, the company behind OtoSet® — the world’s first automated ear-cleaning headphones that can clean earwax buildup in 30 seconds.  FDA-cleared and used in clinics nationwide, OtoSet is transforming how earwax impaction — which affects 35M+ Americans and is a major cause of conductive hearing loss — is treated. A first-generation immigrant from India, Sahil’s journey began with a deeply personal problem — his brother Aadil's lifelong struggle with earwax buildup. What started as a college dorm experiment with 3D-printed prototypes is making ear care more accessible today — an example of how automating a common procedure can make patient care more efficient.  Today, SafKan is taking on two of the biggest challenges in medtech commercialization — ensuring that clinic adoption leads to consistent product use, and fundraising for novel medical devices. SafKan is driving adoption by building awareness and patient demand through social media, with videos of OtoSet racking up 250M+ views, further increasing clinic utilization and patient outcomes.  With $13M in venture funding, partnerships with leaders like GN ReSound, Sonova, and Starkey, and OtoSet being named among the Best Health Designs of 2023 by Fast Company — Sahil is writing the future of ear care by bridging the gap between medtech and patient access.  Links Supporting This Episode:  Safkan Health Website: CLICK HERESahil Diwan LinkedIn page: CLICK HERESafkan Health LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Addiction doesn't announce itself- it emerges silently, often after a routine medical procedure.  Our next guest, James Piacentino, is changing this reality as CEO and Co-Founder of Thrive Genetics.  With over 20 years in healthcare technology and two successful startup exits under his belt, James brings both personal experience and professional expertise to this mission.  After losing his father to opioid addiction following a routine surgery, James dedicated his career to ensuring others wouldn't face the same tragedy. By combining cutting-edge genomics with behavioral psychology, Thrive Genetics helps physicians understand a patient's addiction risk before prescribing pain medication.  Join us to discover how James and his team are pioneering personalized addiction risk management, transforming how healthcare systems approach prevention, and working to spare millions of families from generational trauma. Let's go! Episode Highlights: Curiosity as the foundation for innovation: James emphasizes that deep curiosity about solving meaningful problems is the key driver that gets him out of bed every morning and the most important quality he looks for in team members.Personal tragedy sparking a mission: After losing his father to opioid addiction following a 1982 car accident and back surgery, James dedicated his career to preventing others from experiencing the same generational trauma.Staggering gap in care: Up to 25% of patients undergoing high-pain procedures become addicted to prescribed opioids, yet no proactive addiction risk assessment exists before prescribing pain medication.Science-backed solution: Thrive Genetics combines 10 years of research and over $50M in NIH grants to create addiction risk scores based on both genetic predisposition (50%) and behavioral factors (50%).Thinking beyond the individual: James' North Star is reaching billions of people by preventing not just individual addiction cases, but stopping generational family trauma before it starts. About our Guest:  Thrive Genetics is led by Co-Founder and CEO, James J. Piacentino, MBA, a healthcare technology entrepreneur with over 20 years in tech and life sciences. A graduate of Northwestern University’s Kellogg School of Management, James has built and sold two prior startups, published in the Harvard Business Review, and held senior leadership roles at SAP. He is mentored by Harry Kraemer, former CEO of Baxter International and Kellogg Professor of Management. Links Supporting This Episode:  Thrive Genetics Website: CLICK HEREJame Piacentino LinkedIn page: CLICK HEREThrive Genetics LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: a href="https://forms.gle/PLdcj7ujAGEtunsj6" rel="noopener

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Specialty care shouldn't require months-long wait times or geographic limitations. Our next guest, AJ Patel, is revolutionizing this approach as CEO of TeleMed2U. With over 20 years of healthcare operations experience spanning drugstore chains and specialty pharmacy environments, AJ brings a unique perspective to virtual specialty care delivery.  Having navigated TeleMed2U through significant growth and technological transformation over six years, he's built a network of 500+ providers across 20 specialties nationwide.  Driven by a passion for breaking down geographic barriers and eliminating lengthy wait times, AJ shares how TeleMed2U is democratizing access to specialty care through innovative virtual solutions.  Join us to discover how this technology-enabled platform is connecting patients with expert care regardless of location, transforming outcomes through collaborative medicine, and reshaping the future of specialty healthcare delivery. Let's go! Episode Highlights Proactive Healthcare Philosophy: Treat healthcare like car maintenance - invest in prevention to avoid downstream complications.Technology Pivot: After spending millions building their own tech stack, TeleMed2U pivoted to Advanced MD to focus on patient care.Geographic Solutions: Hub-and-spoke model uses providers across states, including Hawaii clinicians serving mainland patients.Collaborative Care: Seamless coordination between 20 specialties without patients navigating multiple healthcare systems.Future Vision: Measurement-based reimbursement, wearable tech integration, and shared diagnostic centers in rural areas. About our Guest:  AJ Patel has more than 20 years of experience leading Healthcare Operations in the drugstore and specialty pharmacy environment. He currently serves as the Chief Executive Officer of TeleMed2U where he leads the company’s Sales & Operations, Recruiting, Legal and Credentialing/Contracting teams. He collaborates closely with the Advisory Board on the development of clinical programs and future strategy to enhance convenient access to specialty medical care in various markets across the country. Links Supporting This Episode:  TeleMed2U Website: CLICK HEREAJ Patel LinkedIn page: CLICK HERETeleMed2U LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Healthcare investment banking has long followed a volume-driven, cookie-cutter model that prioritizes transactions over transformative outcomes.  Our next guest, Sam Libby, is changing that paradigm as founder and President of TCB Capital Advisors. With over 30 transactions totaling more than $20 billion, Sam brings a mission-driven approach to underinvested healthcare areas like oncology, women's health, and neurodegenerative diseases.  After experiencing healthcare's systemic inefficiencies firsthand during his own patient journey, Sam founded TCB to reject traditional banking models in favor of long-term partnerships that embed early with management teams. His unique three-vertical approach combines banking expertise, clinical advisory, and commercial operations to drive both patient impact and financial success.  Join us to discover how Sam's stewardship mindset is empowering healthcare pioneers to scale life-changing innovations. Let's go! Episode Highlights: Patient-First Philosophy: Sam emphasizes that healthcare professionals are "stewards that owe an obligation to the patient," maintaining focus on improving lives rather than just financial returns.Three-Vertical Approach: TCB Capital Advisors uniquely combines banking services, clinical/scientific advisory, and commercial operations to provide comprehensive support beyond traditional investment banking.Underinvested Healthcare Focus: The firm specifically targets neglected areas like oncology screening, neurodegenerative diseases, and women's health where innovation lags despite significant patient need.Real-World Patient Journey Experience: Sam's personal 10-month journey to reach a memory center despite having concierge care and good insurance highlighted systemic healthcare accessibility issues.Predictive Medicine Future: Sam sees AI-powered prognostic tools like Clarity's breast cancer risk assessment as the most promising innovation for identifying high-risk patients earlier and improving outcomes. About our Guest:  Sam Libby is the founder and President of TCB Capital Advisors, a firm he created to help healthcare companies scale their impact through strategic transactions and long-term growth planning. With a career spanning roles at premier firms like Piper Sandler and Ziegler, Sam brings deep expertise in M&A, capital markets, and private placements, having completed more than 30 deals totaling over $20 billion in transaction value. Known for his hands-on, partner-oriented approach, Sam works closely with management teams to not only execute transactions but to position companies for enduring success. He has a particular focus on underinvested areas of healthcare—including oncology, women’s health, and neurodegenerative disease—and is passionate about supporting founders building scalable solutions with real-world impact. Sam holds degrees in Finance and Accounting from Rutgers University, graduating summa cum laude. Links Supporting This Episode:  TCB Capital Advisors Website: CLICK HERESam Libby LinkedIn page: CLICK HERETCB Capital AdvisorsLinkedIn: CLICK HEREMike...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview: Healthcare organizations are drowning in data, yet struggling to unlock its potential to improve patient outcomes.  Our next guest, Daniel Blumenthal, is transforming this challenge as VP of Strategy at MDClone. With nearly a decade pioneering synthetic data solutions, Daniel possesses a unique perspective bridging healthcare innovation and data privacy protection.  From launching MDClone's North American operations to establishing partnerships with leading health systems like Intermountain Healthcare, he's witnessed firsthand how synthetic data can democratize healthcare insights while safeguarding patient privacy.  Driven by a passion to turn data into actionable intelligence, Daniel shares MDClone's revolutionary vision to enable safe, collaborative discovery across healthcare ecosystems worldwide.  Join us to discover how synthetic data is breaking down barriers, accelerating research, and empowering healthcare professionals to ask better questions of their data. Let's go! Episode Highlights: Building Trust in Healthcare Innovation: Healthcare innovations "live or die" based on whether people trust them, making trust-building as crucial as technology development.Synthetic Data Solves Privacy Challenge: MDClone generates "fake" patient data that protects privacy while maintaining statistical utility for research and analysis.$7 Million Savings at Intermountain: Synthetic data analysis of 100,000+ kidney disease patients helped optimize care interventions and deliver measurable ROI.AI Needs Patient Data Access: Generative AI could automate clinical processes, but requires patient data for training- making synthetic data essential for healthcare AI.Democratizing Healthcare Data: MDClone enables physicians, researchers, and administrators to access robust patient datasets previously blocked by privacy barriers. About our Guest:  Daniel joined MDClone in its early days, launching the company’s operations in North America and establishing its first partnerships with healthcare organizations in the U.S. and Canada. With MDClone’s growth, Daniel now leads efforts to expand key partnerships and develop new software, services, and collaborations around the globe. Based in Chicago, Daniel has extensive experience building startup ecosystems and supporting entrepreneurs in the U.S. and Israel, having served as Deputy Consul for Economic Affairs at the Government of Israel Economic Mission in Chicago. Links Supporting This Episode:  MDClone Website: CLICK HEREDaniel Blumenthal LinkedIn page: CLICK HEREMDClone LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: a...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Commercial real estate transactions can make or break a healthcare practice, yet most providers navigate these critical decisions without proper representation.  Our next guest, Colin Carr, is changing that reality as CEO and founder of CARR, the nation's leading healthcare real estate advisor.  With over 17 years of experience and more than a thousand completed transactions, Colin has saved healthcare providers hundreds of millions of dollars by exclusively representing their interests as tenants and buyers. Leading a team of nearly 150 experts coast-to-coast, Colin serves over 6,000 active clients ranging from solo practitioners to large private equity-backed groups.  Driven by a passion to level the playing field in commercial real estate, Colin shares how CARR's strategic approach transforms what was once an unfair fight into substantial savings, time efficiency, and peace of mind.  Join us to discover how proper representation can maximize profitability through real estate. Let's go! Episode Highlights: The $400,000 Wake-Up Call: Colin witnessed healthcare providers overpaying by hundreds of thousands of dollars due to lack of representation, inspiring him to launch CARR in 2009.Less Than 1% Work for Tenants: Unlike other industries, less than 1% of commercial real estate agents exclusively represent tenants and buyers, leaving healthcare providers vulnerable.Three Costly Mistakes: The biggest errors are doing it yourself, negotiating with only one landlord, and lacking strategy—mistakes that can cost $300,000-$500,000 per deal.6,000+ Active Clients Nationwide: CARR now serves over 6,000 healthcare providers across all 50 states with a team of 150+ experts, completing over 1,000 transactions.Class B Office Opportunities: Post-pandemic, the best deals are in Class B office spaces where landlords are motivated to offer higher build-out allowances and more free rent. About our Guest:  Colin Carr is a commercial real estate expert who has successfully completed over a thousand commercial real estate transactions while saving his clients hundreds of millions of dollars. Colin founded and scaled CARR, a nationwide commercial real estate company, to exclusively represent the unique needs and interests of healthcare providers. He has mastered several niches in the healthcare real estate industry and is passionate about helping others “Maximize Your Profitability Through Real Estate®”.  Today, CARR is the nation’s leading healthcare real estate advisor with a team of almost 150 experts that span coast-to-coast. Every year, thousands of healthcare providers trust CARR to help them achieve the most favorable terms on their lease and purchase negotiations. Links Supporting This Episode:  Carr Healthcare Website: CLICK HERECarr Healthcare LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  The fight to save critically ill patients has remained largely unchanged for over 70 years- until now.  Our next guest, Doug Evans, is revolutionizing critical care as President and CEO of Lungpacer Medical.  With over three decades of medical device innovation and 300+ issued patents, Doug's personal mission was born from tragedy when his 14-year-old son required mechanical ventilation during his cancer battle.  This heartbreaking experience drove Doug to tackle ventilator-induced diaphragm dysfunction, a condition that affects millions and contributes to the staggering 50% mortality rate among ventilated patients.  Through groundbreaking neurostimulation technology, Doug and his team achieved the impossible—FDA approval for the first device designed to strengthen patients' diaphragms while on ventilation.  Join us to discover how Lungpacer's pioneering AeroPace System is transforming outcomes, reducing ventilator dependency, and offering hope to families facing their darkest hours. Let's go! Episode Highlights: Personal Mission Born from Tragedy: Doug founded Lungpacer Medical after his 14-year-old son Cameron required mechanical ventilation during his cancer battle, driving his commitment to improve outcomes for critically ill patients.Historic FDA Breakthrough: In December 2024, Lungpacer's AeroPace System became the first and only FDA-approved device designed to strengthen the diaphragm in mechanically ventilated patients.Proven Clinical Results: The AeroPace System reduces ventilator time by 3 days, decreases 30-day ventilator dependency risk by 35%, and cuts re-ventilation risk by 60%.Life-Saving Patient Impact: Doug shared the powerful story of their first U.S. patient who had given up hope and wanted life support removed, but was saved through their technology and went home for the holidays.Next-Generation Innovation: The investigational AeroNova System promises continuous diaphragm stimulation with every breath, potentially improving not just muscle strength but also lung, brain, and heart function. About our Guest: Doug Evans brings over three decades of medical device innovation to his role as President and CEO of Lungpacer Medical Inc. As a serial entrepreneur and inventor, Doug has developed more than 3 00 issued patents covering pioneering devices that have revolutionized healthcare for over 15 million patients worldwide.  Doug's journey with Lungpacer began with the heartbreaking experience of his 14-year-old son's struggle with mechanical ventilation during his cancer battle. After losing his son, Doug committed himself to solving the clinical challenges that affect millions of critically ill patients who depend on mechanical ventilation to survive.  His determination has led to the development of revolutionary neurostimulation technology that works "like lifting weights to build strength" for patients' diaphragms while they remain on mechanical ventilation. This breakthrough approach addresses ventilator-induced diaphragm dysfunction, a major barrier to patient recovery that contributes to the staggering mortality rates in intensive care units.  Doug's personal mission drives Lungpacer's vision: to free patients from prolonged mechanical ventilation and preserve their overall health during critical illness. BeforeLungpacer, Doug's career has spanned leadership roles across...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Life-saving drugs exist for many diseases, yet millions still lack access due to manufacturing inefficiencies and high costs.  Our next guest, Reza Farahani, is revolutionizing this challenge as founder and CEO of Katalyze AI.  As a third-time founder with two successful exits and strategic consulting experience at BCG, Reza brings a unique perspective to biomanufacturing optimization.  His company is pioneering agentic AI solutions that act as specialized co-pilots, combining the expertise of data engineers, scientists, and process engineers into powerful automation tools.  Driven by a mission to make essential medicines accessible and affordable for everyone, Reza shares how Katalyze AI is helping pharmaceutical companies increase efficiency, reduce costs, and minimize waste.  Join us to discover how AI-powered biomanufacturing is transforming drug production and creating a future where life-saving treatments are within reach for all communities. Let's go! Episode Highlights: Bias Towards Action: Reza's #1 advice for entrepreneurs is taking action over endless planning - he even encourages new team members to make mistakes in their first few monthsMillion Dose Impact: Katalyze AI helped a pharmaceutical company ship one million extra vaccine doses without any capital investment, just by optimizing standard operating proceduresData Goldmine Unlocked: The company created specialized digitization tools to extract valuable insights from unstructured PDFs and lab notes that were previously inaccessibleFuture of Bio-Manufacturing: Reza envisions making everyday products like milk through bio-manufacturing at 10X lower costs with 90% less energy and 60% less waterAgentic AI Solutions: Katalyze AI acts as a specialized co-pilot combining data engineering, science, and process engineering expertise to help one person solve complex manufacturing problemsRetryClaude can make mistakes. Please double-check responses. About our Guest:  Reza is a third-time founder with two successful exits, reflecting his strong track record in launching and scaling technology ventures.  Before founding Katalyze AI, he gained strategic consulting experience at BCG, where he focused on driving data-driven solutions for diverse industries.  He holds a Master’s degree in System Design Engineering from the University of Waterloo. His leadership establishes the company as a trusted partner in biomanufacturing. Links Supporting This Episode:  Katalyze AI Website: CLICK HEREReza Farahani LinkedIn page: CLICK HEREKatalyze AI LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK...

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE Episode Overview:  Healthcare equity isn't just a policy goal- it's a moral imperative that requires bold leadership and innovative solutions.  Our next guest, Dr. Tyler Evans, embodies this mission as CEO and co-founder of Wellness Equity Alliance.  With extensive experience on the front lines of global health crises, from Ebola outbreaks in sub-Saharan Africa to serving as New York City's first Chief Medical Officer during COVID-19, Tyler brings unparalleled expertise to vulnerable communities worldwide.  His work spans refugees, LGBTQIA+ populations, indigenous communities, and those experiencing homelessness.  Driven by a passion to bridge the gaps between public health and healthcare delivery, Tyler shares his transformative approach to building trusted community partnerships and addressing the intersection of pandemics, poverty, and politics.  Join us to discover how the Wellness Equity Alliance is pioneering locally-nuanced healthcare access and why true health equity demands systemic change. Let's go! Episode Highlights: Personal Loss to Global Mission: Lost family by 21, driving dedication to vulnerable communities worldwide.NYC COVID Leadership: First Chief Medical Officer, administered 2+ million COVID vaccines.Four-Pillar Strategy: Partnerships, workforce development, data modernization, community trust.New Book Release: "Pandemics, Poverty, and Politics" examines pandemic drivers 1899-COVID.Breaking Silos: Integrating healthcare, government, education, and social services. About our Guest:  Dr. Tyler Evans is an experienced and passionate infectious diseases and public health expert who has been on the front lines of major disease outbreaks (including two Ebola outbreaks) around the globe. Outside the U.S., he has mostly worked in sub-Saharan Africa, South Asia, and the Middle East with organizations like Doctors without Borders (Medecins Sans Frontieres) and Partners in Health. He is a tireless champion for medical humanitarianism and health equity, working with special populations across the world – including migrants (specifically refugees, asylees and victims of human trafficking), the LGBTQIA+ (with a special focus on transgender populations), people experiencing homelessness, people struggling with substance use, and indigenous communities.He was also the first Chief Medical Officer for New York City - leading the Office of Emergency Management’s (OEM) COVID-19 medical response. Dr. Evans is the CEO, chief medical officer and co-founder of Wellness and Equity Alliance, a national alliance of public health clinicians and supporting operations committed to transforming health care delivery to vulnerable communities with a focus on effective COVID-19 clinical services in strategic settings, and is an adjunct associate professor at University of Southern California (USC) Keck School of Medicine, Department of Population and Public Health Sciences. Links Supporting This Episode:  Wellness Equity Alliance Website: CLICK HEREDr. Tyler Evans LinkedIn page: CLICK HEREDr. Tyler Evans Website: CLICK HEREMike Biselli LinkedIn page:...